Epigral (BOM:543332) Other Net Income (Loss) : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Epigral Other Net Income (Loss)?

Epigral's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₹-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Epigral's quarterly Other Net Income (Loss) increased from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹0 Mil) but then declined from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil).

Epigral's annual Other Net Income (Loss) increased from Mar. 2022 (₹-0 Mil) to Mar. 2023 (₹0 Mil) but then stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Epigral Other Net Income (Loss) Historical Data

The historical data trend for Epigral's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Other Net Income (Loss) Chart

Epigral Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Get a 7-Day Free Trial

Epigral Quarterly Data
	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial											-	-	-	-	-

Epigral Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Epigral Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Epigral's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigral (BOM:543332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

EPIGRAL:India

Address

Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.meghmanifinechem.com

Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines